These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28367260)

  • 21. An internally controlled, double-blind comparison of the efficacy of onabotulinumtoxinA and abobotulinumtoxinA.
    Nettar KD; Yu KC; Bapna S; Boscardin J; Maas CS
    Arch Facial Plast Surg; 2011; 13(6):380-6. PubMed ID: 21690460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Intradermal Injection of Botulinum Toxin A for Facial Lifting.
    Atwa EM; Nasr MM; Ebrahim HM
    J Clin Aesthet Dermatol; 2020 Dec; 13(12):22-26. PubMed ID: 33488914
    [No Abstract]   [Full Text] [Related]  

  • 23. Subcutaneous vs intramuscular botulinum toxin: split-face randomized study.
    Gordin EA; Luginbuhl AL; Ortlip T; Heffelfinger RN; Krein H
    JAMA Facial Plast Surg; 2014; 16(3):193-8. PubMed ID: 24699554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duration of action of abobotulinumtoxina and onabotulinumtoxina: a randomized, double-blind study using a contralateral frontalis model.
    Nestor MS; Ablon GR
    J Clin Aesthet Dermatol; 2011 Sep; 4(9):43-9. PubMed ID: 21938269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intradermal Microdroplet Injection of Diluted Incobotulinumtoxin-A for Sebum Control, Face Lifting, and Pore Size Improvement.
    Park JY; Cho SI; Hur K; Lee DH
    J Drugs Dermatol; 2021 Jan; 20(1):49-54. PubMed ID: 33400411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
    Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
    Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin type A treatment to the upper face: retrospective analysis of daily practice.
    Prager W; Huber-Vorländer J; Taufig AZ; Imhof M; Kühne U; Weissberg R; Kuhr LP; Rippmann V; Philipp-Dormston WG; Proebstle TM; Roth C; Kerscher M; Ulmann C; Pavicic T
    Clin Cosmet Investig Dermatol; 2012; 5():53-8. PubMed ID: 22791996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
    Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin type a injection for lateral canthal rhytids : effect on tear film stability and tear production.
    Ho MC; Hsu WC; Hsieh YT
    JAMA Ophthalmol; 2014 Mar; 132(3):332-7. PubMed ID: 24385079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intradermal Micro-Dosing of AbobotulinumtoxinA for Face-Lifting: How Long Does It Last?
    Wanitphakdeedecha R; Yan C; Apinuntham C; Rojanavanich V; Cembrano KAG; Eimpunth S; Manuskiatti W
    Dermatol Ther (Heidelb); 2020 Aug; 10(4):779-789. PubMed ID: 32591944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of intradermal abobotulinumtoxinA on facial erythema of rosacea.
    Bloom BS; Payongayong L; Mourin A; Goldberg DJ
    Dermatol Surg; 2015 Jan; 41 Suppl 1():S9-16. PubMed ID: 25548852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intradermal injection of incobotulinumtoxinA for face lifting.
    Wanitphakdeedecha R; Nokdhes YN; Patthamalai P; Yan C; Techapichetvanich T; Phothong W; Eimpunth S; Manuskiatti W
    Dermatol Ther; 2020 Nov; 33(6):e13944. PubMed ID: 32614987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
    Beer KR; Julius H; Dunn M; Wilson F
    J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial.
    Marciniak C; McAllister P; Walker H; Brashear A; Edgley S; Deltombe T; Khatkova S; Banach M; Gul F; Vilain C; Picaut P; Grandoulier AS; Gracies JM;
    PM R; 2017 Dec; 9(12):1181-1190. PubMed ID: 28625615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intradermal Botulinum Toxin A Injection for Scalp Sebum Secretion Regulation: A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Prospective Study in Chinese Subjects.
    Li Y; Chen X; Luo X; Li L; Lin Y
    Aesthet Surg J; 2023 Jan; 43(1):NP38-NP48. PubMed ID: 36004504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A two-center, open-label, randomized, split-face study to assess the efficacy and safety of one versus three intradermal injection sites of abobotulinumtoxinA in the treatment of lateral periocular rhytides.
    Fabi SG; Sundaram H; Guiha I; Goldman MP
    J Drugs Dermatol; 2013 Aug; 12(8):932-7. PubMed ID: 23986168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids.
    Hui JI; Lee WW
    Ophthalmic Plast Reconstr Surg; 2007; 23(6):433-8. PubMed ID: 18030112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Prospective, Split-Face, Randomized, Double-Blind Study Comparing OnabotulinumtoxinA to IncobotulinumtoxinA for Upper Face Wrinkles.
    Yeilding RH; Fezza JP
    Plast Reconstr Surg; 2015 May; 135(5):1328-1335. PubMed ID: 25919246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study between intradermal botulinum toxin A and fractional microneedle radiofrequency (FMR) for the treatment of primary axillary hyperhidrosis.
    Rummaneethorn P; Chalermchai T
    Lasers Med Sci; 2020 Jul; 35(5):1179-1184. PubMed ID: 31939036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comparative
    Cao Y; Yang JP; Zhu XG; Zhu J; Chang HQ; Guo SH; Luo D; Zhou BR
    Biomed Res Int; 2018; 2018():6235742. PubMed ID: 30057908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.